Reverse (5′→3′) Oligonucleotide Synthesis

Overview

What Is Reverse (5′→3′) Oligonucleotide Synthesis?

Conventional phosphoramidite oligonucleotide synthesis is performed from the 3′ end toward the 5′ end of the growing oligonucleotide. In this standard 3′→5′ manufacturing strategy, the first nucleoside is attached to the solid support through its 3′ position, and each additional monomer is coupled as the chain grows toward the 5′ terminus.

Reverse (5′→3′) oligonucleotide synthesis uses reverse-polarity phosphoramidite chemistry to extend the growing oligo in the opposite direction. This is not a separate product category; it is a specialized manufacturing strategy used when the desired final oligonucleotide cannot be produced efficiently or correctly by conventional synthesis alone.

Some customer requests are so structurally specific that reverse synthesis chemistry is the only practical route to the target molecule. Bio-Synthesis routinely performs this type of synthesis for custom oligonucleotides requiring reverse-polarity linkages, inverted bases, selected modified nucleotides, chimeric DNA/RNA architectures, and other difficult constructs.

Customer-friendly design note: You do not need to know in advance whether your oligo requires conventional synthesis, reverse synthesis, or a hybrid strategy. Bio-Synthesis reviews the target sequence, polarity map, modification placement, purification requirements, and final application to select the best manufacturing route.

Direction of Synthesis

Conventional 3′→5′ vs Reverse 5′→3′ Synthesis

The final sequence may be written 5′→3′, but the chemistry used to build the oligo can proceed in different directions depending on the desired architecture.

Animated Synthesis Direction

moving P icon shows chain-extension direction

Conventional Synthesis (3′ → 5′)

Builds from 3′ end toward 5′ end

3′

P

➜5′

P moves as new nucleotides are added

1 Detritylation›2 Coupling›3 Capping›4 Oxidation

VS

Reverse Synthesis (5′ → 3′)

Builds from 5′ end toward 3′ end

5′

P

➜3′

P moves as new nucleotides are added

1 Detritylation›2 Coupling›3 Capping›4 Oxidation

P Reverse Phosphoramidite (5′ building block)P Standard Phosphoramidite (3′ building block) Nucleotide

Direction Matters

Reverse synthesis enables reverse-polarity, inverted-base, and other oligonucleotide architectures that cannot be produced using conventional synthesis alone.

Specialized Building Blocks

Reverse phosphoramidites are specifically designed to support efficient 5′→3′ oligonucleotide synthesis.

High Fidelity Manufacturing

Optimized synthesis chemistry improves coupling efficiency, resulting in high-purity, full-length oligonucleotides.

Proven Expertise

Bio-Synthesis has decades of experience manufacturing complex custom DNA and RNA oligonucleotides.

Why Reverse Synthesis Is Needed

When Conventional Synthesis Is Not Enough

Reverse synthesis is used when the requested oligo architecture cannot be achieved by a single normal 3′→5′ route.

3–3

3′–3′ Junctions

Create reverse-polarity backbone junctions and terminal structures that cannot be assembled by standard synthesis alone.

5–5

5′–5′ Junctions

Install 5′–5′ linkages or reverse-polarity caps for specialty DNA/RNA architectures.

INV

Inverted Bases

Support inverted dT, inverted ddT, inverted abasic residues, and other reverse-oriented terminal or internal modifications.

MOD

Modified Nucleotides

Place certain modified bases, sugars, spacers, or labels in positions that require reverse chemistry.

MIX

Hybrid Direction Strategy

Use forward and reverse synthesis together for internal inversions or multi-domain oligonucleotide constructs.

QC

Difficult Custom Oligos

Enable oligos that require advanced route planning, purification, and analytical confirmation.

Supported Chemistries

Reverse Synthesis Chemistries for Custom Oligos

The items below are organized by typical support level. “Common” means frequently supported in custom oligo manufacturing; “Specialty” and “Custom evaluation” mean Bio-Synthesis can evaluate feasibility, sourcing, custom reagent preparation, and process development.

Select a chemistry family

DNA Reverse Synthesis Chemistries

Common reverse DNA synthesis bases. The items below are representative options for finished oligonucleotide manufacturing, not a reagent sales catalog.

Reverse synthesis chemistry	Example notation	Base / scaffold	Typical support	Typical use
dA-5′ reverse phosphoramidite	[5′-dA]	A	Common	Reverse DNA synthesis, reverse-polarity junctions, inverted DNA constructs
dC-5′ reverse phosphoramidite	[5′-dC]	C	Common	Reverse DNA synthesis and custom DNA architectures
dG-5′ reverse phosphoramidite	[5′-dG]	G	Common	Reverse DNA synthesis and reverse-polarity strand design
dT-5′ reverse phosphoramidite	[5′-dT]	T	Common	Reverse DNA synthesis, inverted dT, adapter and blocker designs
dU-5′ reverse phosphoramidite	[5′-dU]	U	Common / project dependent	Specialty DNA constructs where dU is required

Modified DNA Reverse Synthesis Chemistries

Reverse synthesis with selected modified DNA bases. The items below are representative options for finished oligonucleotide manufacturing, not a reagent sales catalog.

Reverse synthesis chemistry	Example notation	Base / scaffold	Typical support	Typical use
5-Me-dC-5′ reverse phosphoramidite	[5′-5Me-dC]	5mC	Common / specialty	Methylated DNA and reverse-polarity modified DNA
deoxyinosine-5′ reverse phosphoramidite	[5′-dI]	I	Common / specialty	Universal-base reverse synthesis and pairing studies
5-Br-dU-5′ reverse phosphoramidite	[5′-5Br-dU]	5-Br-dU	Specialty	Photoreactive or analog DNA designs
Amino-dT-5′ reverse-compatible design	[5′-Amino-dT]	modified T	Specialty / custom evaluation	Functional handle placement and conjugation-ready oligos
Biotin-dT-5′ reverse-compatible design	[5′-Biotin-dT]	modified T	Specialty / custom evaluation	Affinity capture, probes and labeled constructs
Fluorescein-dT-5′ reverse-compatible design	[5′-FAM-dT]	modified T	Specialty / custom evaluation	Fluorescent probes and reverse-polarity labeled oligos

RNA Reverse Synthesis Chemistries

Reverse RNA synthesis chemistries. The items below are representative options for finished oligonucleotide manufacturing, not a reagent sales catalog.

Reverse synthesis chemistry	Example notation	Base / scaffold	Typical support	Typical use
rA-5′ reverse phosphoramidite	[5′-rA]	A	Common / specialty	Reverse RNA synthesis and inverted RNA architectures
rC-5′ reverse phosphoramidite	[5′-rC]	C	Common / specialty	Reverse RNA synthesis and RNA structure studies
rG-5′ reverse phosphoramidite	[5′-rG]	G	Common / specialty	Reverse RNA synthesis and chimeric RNA constructs
rU-5′ reverse phosphoramidite	[5′-rU]	U	Common / specialty	Reverse RNA synthesis, RNA folding and modified RNA designs

2′-OMe / 2′-F Reverse Synthesis Chemistries

Reverse modified RNA chemistries. The items below are representative options for finished oligonucleotide manufacturing, not a reagent sales catalog.

Reverse synthesis chemistry	Example notation	Base / scaffold	Typical support	Typical use
2′-OMe-A-5′ reverse phosphoramidite	[5′-2OMeA]	A	Common / specialty	siRNA, ASO and nuclease-resistant reverse-polarity designs
2′-OMe-C-5′ reverse phosphoramidite	[5′-2OMeC]	C	Common / specialty	Modified RNA and therapeutic discovery constructs
2′-OMe-G-5′ reverse phosphoramidite	[5′-2OMeG]	G	Common / specialty	ASO-style modified RNA designs
2′-OMe-U-5′ reverse phosphoramidite	[5′-2OMeU]	U	Common / specialty	siRNA, ASO and RNA stability studies
2′-F-A-5′ reverse phosphoramidite	[5′-2FA]	A	Specialty / custom evaluation	Therapeutic-style RNA analog research
2′-F-C-5′ reverse phosphoramidite	[5′-2FC]	C	Specialty / custom evaluation	Therapeutic-style RNA analog research
2′-F-G-5′ reverse phosphoramidite	[5′-2FG]	G	Specialty / custom evaluation	Therapeutic-style RNA analog research
2′-F-U-5′ reverse phosphoramidite	[5′-2FU]	U	Specialty / custom evaluation	Therapeutic-style RNA analog research

Spacers / Abasic Reverse Synthesis Chemistries

Reverse spacers and non-nucleotide segments. The items below are representative options for finished oligonucleotide manufacturing, not a reagent sales catalog.

Reverse synthesis chemistry	Example notation	Base / scaffold	Typical support	Typical use
Reverse Spacer C3	[5′-SpC3]	spacer	Common / specialty	Short spacing, terminal control and non-nucleotide reverse segments
Reverse Spacer C6	[5′-SpC6]	spacer	Common / specialty	Flexible spacing, conjugation distance and linker architecture
Reverse Spacer C9	[5′-SpC9]	spacer	Specialty / custom evaluation	Longer spacer and specialty constructs
Reverse Spacer C12	[5′-SpC12]	spacer	Specialty / custom evaluation	Longer hydrophobic spacer designs
Reverse HEG / Spacer 18	[5′-HEG]	HEG	Common / specialty	Hydrophilic spacing, loops and distance-control designs
Reverse dSpacer / abasic site	[5′-dSp]	abasic	Common / specialty	Abasic models, blocking and reverse-polarity non-base residues
Reverse abasic chemistry	[5′-Ab]	abasic	Common / specialty	Inverted abasic and THF-like reverse-polarity designs

Specialty Reverse Synthesis Chemistries

Project-dependent reverse synthesis chemistries. The items below are representative options for finished oligonucleotide manufacturing, not a reagent sales catalog.

Reverse synthesis chemistry	Example notation	Base / scaffold	Typical support	Typical use
LNA-A-5′ reverse-compatible design	[5′-LNA-A]	A	Specialty / custom evaluation	High-affinity reverse-polarity oligos
LNA-C-5′ reverse-compatible design	[5′-LNA-C]	C	Specialty / custom evaluation	High-affinity reverse-polarity oligos
LNA-G-5′ reverse-compatible design	[5′-LNA-G]	G	Specialty / custom evaluation	High-affinity reverse-polarity oligos
LNA-T/U-5′ reverse-compatible design	[5′-LNA-T/U]	T/U	Specialty / custom evaluation	High-affinity reverse-polarity oligos
MOE-A-5′ reverse-compatible design	[5′-MOE-A]	A	Specialty / custom evaluation	ASO-style specialty chemistry
MOE-C-5′ reverse-compatible design	[5′-MOE-C]	C	Specialty / custom evaluation	ASO-style specialty chemistry
MOE-G-5′ reverse-compatible design	[5′-MOE-G]	G	Specialty / custom evaluation	ASO-style specialty chemistry
MOE-U/T-5′ reverse-compatible design	[5′-MOE-U/T]	U/T	Specialty / custom evaluation	ASO-style specialty chemistry
Project-specific reverse synthesis route	[Custom]	varies	Custom evaluation	Special designs requiring custom reagent sourcing or process development

Important scope note: Bio-Synthesis provides finished custom oligonucleotides manufactured using reverse synthesis strategies. This table is not a reagent catalog and does not imply that Bio-Synthesis sells standalone reverse phosphoramidites.

Bio-Synthesis Capability

Reverse Synthesis Capability Summary

Finished Oligonucleotide Manufacturing Capabilities

Bio-Synthesis evaluates each sequence for synthetic route, modification compatibility, purification, and QC.

Capability	Support	Design Notes
Reverse DNA synthesis	Supported routinely	dA, dC, dG, dT and selected modified DNA bases.
Reverse RNA synthesis	Supported / project dependent	Reverse RNA designs require sequence and deprotection review.
Reverse 2′-O-methyl synthesis	Supported / project dependent	Useful for siRNA, ASO, chimeric RNA/DNA and stability studies.
Reverse 2′-F synthesis	Specialty / custom evaluation	Therapeutic-style analog projects require feasibility review.
LNA / MOE reverse-compatible designs	Custom evaluation	Evaluated based on reagent access, coupling behavior, sequence and QC needs.
Mixed forward/reverse synthesis	Supported / project dependent	Used for internal inversions, polarity switches and multi-domain constructs.
Custom reverse synthesis strategy	Supported	Bio-Synthesis determines whether normal, reverse, or hybrid synthesis is the best route.

Manufacturing Workflow

How Bio-Synthesis Handles Reverse Synthesis Projects

Customers can submit the desired final construct. Our technical team determines the manufacturing strategy.

1

Customer Design

Sequence and desired final architecture

2

Feasibility Review

Polarity, chemistry, scale, application

3

Route Selection

Forward, reverse, or mixed strategy

4

Custom Synthesis

Solid-phase oligo manufacturing

5

Purification

Desalt, HPLC, PAGE or custom method

6

QC Release

Mass, purity, yield and CoA

Manufacturing Route Decision

When Does Bio-Synthesis Choose Conventional, Reverse, or Hybrid Synthesis?

Customers can submit the desired final oligo. Bio-Synthesis evaluates the sequence, modifications, polarity, and QC requirements to select the best manufacturing route.

Customer sequence submitted

Sequence, modification map, polarity requirement, scale, purification and QC target

Can the construct be made by standard 3′→5′ phosphoramidite chemistry?

Bio-Synthesis evaluates synthesis direction, reagent compatibility, coupling risk and purification strategy.

Yes

Conventional 3′→5′ Synthesis

Used for most standard DNA, RNA and modified oligos when no reverse-polarity constraint is present.

No

Reverse 5′→3′ Synthesis

Used when reverse-polarity linkages, inverted terminal architecture or specific modification placement requires reverse chemistry.

MIXED

Hybrid Forward / Reverse Strategy

Used for internal polarity switches, multi-domain constructs, or complex oligos requiring both synthesis directions.

Optimal manufacturing strategy selected

Route planning, custom synthesis, purification, analytical QC and finished oligo release.

Common Design Challenges We Solve

Reverse Synthesis for Difficult Oligonucleotide Projects

Reverse synthesis is often requested when the desired oligo cannot be made by a simple standard route. Bio-Synthesis evaluates the chemistry and manufacturing path before recommending the final synthesis strategy.

3′–3′ and 5′–5′ Linkage Construction

Reverse-polarity junctions can require specialized route planning and reverse-compatible chemistry.

Terminal or internal polarity switches
Inverted-base architectures
Adapter and blocker designs

Modified Base Placement

Certain modifications become difficult when placement, directionality or deprotection compatibility constrains the synthesis route.

5-Me-dC, dI, dU and analogs
2′-OMe and 2′-F RNA
Functionalized bases and labels

Complex Chimeric Constructs

DNA/RNA, modified RNA and multi-domain constructs may require hybrid forward/reverse synthesis strategies.

DNA/RNA chimeras
ASO and siRNA-style designs
Aptamer and probe constructs

Purification of Difficult Products

Reverse synthesis products may require different purification conditions to remove truncated or side-product species.

HPLC method selection
PAGE for high resolution
Custom purity targets

Sequence-Dependent Coupling Issues

High GC content, secondary structure, long length or heavy modification load can reduce coupling efficiency.

Difficult sequences
Multiple modifications
Long oligos

Finished-Oligo Documentation

Complex constructs benefit from clear annotation, identity confirmation and analytical release documentation.

Mass spectrometry
Analytical HPLC
Certificate of analysis

Design Guidance

Design Considerations for Reverse Synthesis

Reverse synthesis is often requested when the desired oligo cannot be made by a simple standard route. Bio-Synthesis evaluates the chemistry and manufacturing path before recommending the final synthesis strategy.

MAP

Polarity Map

Clearly define 5′ and 3′ ends, internal inversion points, and any 3′–3′ or 5′–5′ junctions.

MOD

Modification Compatibility

Some modified bases or labels require altered coupling, deprotection, or purification conditions.

RNA

RNA / Chimeric Oligos

RNA and DNA/RNA chimeras require special attention to protecting groups and deprotection compatibility.

LEN

Length and Scale

Long or highly modified constructs may require adjusted synthesis scale and purification strategy.

PUR

Purification Method

HPLC or PAGE is recommended for complex reverse-polarity or highly modified oligos.

MS

Analytical QC

Mass confirmation and analytical purity are recommended for route-sensitive constructs.

Applications

Applications of Reverse (5′→3′) Oligo Synthesis

Keep Oligopaint connected to spatial imaging while separating it clearly from chromosome painting and RNA transcriptomic FISH pages.

INV

Inverted-Base Oligos

Inverted dT, inverted ddT, inverted abasic residues and other reverse-oriented modifications.

NGS

Sequencing Adapters

Reverse-polarity blockers, adapter control and unusual terminal architectures.

ASO

Therapeutic Oligos

ASO, siRNA, chimeric and modified oligo research constructs.

APT

Aptamers

Polarity-inverted aptamers and protected binding constructs.

RNA

RNA Structure

Reverse RNA, 2′-OMe, and chimeric constructs for structure-function studies.

NANO

DNA Nanotechnology

Reverse-polarity junctions, caps and special strand architectures.

CIRC

Circularizable Constructs

Designs requiring polarity control, ligation control or unusual junction placement.

PROBE

Probes and Blockers

Probe designs, blocker oligos and extension-resistant constructs.

Quality and Deliverables

Recommended Purification and QC

PUR

Purification

Desalt for simple screening oligos
HPLC for many modified oligos
PAGE for long or highly resolved constructs

MS

Identity Confirmation

ESI-MS or MALDI-TOF
Analytical HPLC where appropriate
Sequence and modification annotation

DOC

Documentation

Certificate of analysis
Mass and purity data
Custom concentration or buffer by request

Related Services

Related Oligonucleotide Synthesis Services

INV

Inverted Base Modified Oligos

3′ inverted dT, 5′ inverted ddT, inverted RNA, abasic and reverse-polarity designs.

Learn more

2→5

2′→5′ Linked Oligonucleotides

Non-natural 2′→5′ linkages for backbone engineering and nuclease-resistance studies.

Learn more

BASE

Base-Modified Oligonucleotides

Modified bases, universal bases, methylated bases and nucleobase analogs.

Learn more

Contact & Quote Request

Need help determining whether your oligo requires reverse synthesis?

Send your target sequence, desired modifications, intended orientation, scale, purification, and QC requirements. Bio-Synthesis will evaluate whether the construct can be manufactured by conventional 3′→5′ synthesis, reverse 5′→3′ synthesis, or a hybrid forward/reverse route.

Request a Quote Speak to a Scientist

Need help before quoting?

Email: info@biosyn.com

Phone: 800-227-0627 (US/CAN)

Phone: +001-972-420-8505 (INT)

What to Send

Sequence
Modification positions
Desired polarity map
Scale and purification
QC requirements

What We Review

Bio-Synthesis evaluates chemistry, route feasibility, purification strategy and final analytical release requirements.

Header

Header

Header

Oligonucleotide Services

Analytical & QC Services

Development Services

Custom Oligo Synthesis

Formulation & Product Development

Custom Peptide Type

Custom Peptide Synthesis

Peptide Modifications

Peptide Purification and Analytical Services

Specialty Peptides

Catalog Peptide

Molecular Biology Services

Bioconjugation Service

Biomolecule Conjugation

Immunochemistry Services

Antibody Engineering and Conjugation

Bioanalytical Services

Educational Resources

Scientific Tools

Educational Resources

Scientific Tools

Online Quotes

Online Order

Printable Forms

MSDS / SDS Sheets

Additional Resources

Reverse (5′→3′) Oligonucleotide Synthesis

What Is Reverse (5′→3′) Oligonucleotide Synthesis?

Conventional 3′→5′ vs Reverse 5′→3′ Synthesis

Animated Synthesis Direction

Conventional Synthesis (3′ → 5′)

Reverse Synthesis (5′ → 3′)

Direction Matters

Specialized Building Blocks

High Fidelity Manufacturing

Proven Expertise

When Conventional Synthesis Is Not Enough

3′–3′ Junctions

5′–5′ Junctions

Inverted Bases

Modified Nucleotides

Hybrid Direction Strategy

Difficult Custom Oligos

Reverse Synthesis Chemistries for Custom Oligos

Select a chemistry family

DNA Reverse Synthesis Chemistries

Modified DNA Reverse Synthesis Chemistries

RNA Reverse Synthesis Chemistries

2′-OMe / 2′-F Reverse Synthesis Chemistries

Spacers / Abasic Reverse Synthesis Chemistries

Specialty Reverse Synthesis Chemistries

Reverse Synthesis Capability Summary

Finished Oligonucleotide Manufacturing Capabilities

How Bio-Synthesis Handles Reverse Synthesis Projects

When Does Bio-Synthesis Choose Conventional, Reverse, or Hybrid Synthesis?

Customer sequence submitted

Can the construct be made by standard 3′→5′ phosphoramidite chemistry?

Conventional 3′→5′ Synthesis

Reverse 5′→3′ Synthesis

Hybrid Forward / Reverse Strategy

Optimal manufacturing strategy selected

Custom Reverse Synthesis Expertise Beyond Catalog Oligos

Decades of Experience

Broad Modification Support

Complex Oligo Manufacturing

Flexible Purification

Comprehensive QC

Reverse Synthesis for Difficult Oligonucleotide Projects

3′–3′ and 5′–5′ Linkage Construction

Modified Base Placement

Complex Chimeric Constructs

Purification of Difficult Products

Sequence-Dependent Coupling Issues

Finished-Oligo Documentation

Design Considerations for Reverse Synthesis

Polarity Map

Modification Compatibility